This book is about asymmetric David & Goliath partnerships in pharmaceutical R&D--bilateral arrangements in which one partner is a smaller bioscience or academic organization (David) and the other a large multinational corporation (Goliath).
The past decade has seen a paradigm shift in how medicines and other therapies are discovered, developed and commercialized.
The new distributed model of R&D seamlessly blends external partnerships with in-house efforts to generate innovative medicin.
Phizz Rx Publishing Biopharma r&d partnerships: from david & goliath to networked r&d, paperback/robert thong
